Related Experiment Video
Updated: Mar 17, 2026
05:48
Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice
Published on: September 26, 2019
10.0K
Emphysema: coiling up the lungs, trick or treat?
1Centre of Respiratory Endoscopy and Laser‑Theraphy, A.O. Spedali Civili di Brescia, Brescia, Italy - michela.bezzi@spedalicivili.brescia.it.
Minerva Medica
|July 19, 2016
Summary
Lung volume reduction coil (LVRC) treatment shows significant clinical improvements for severe emphysema patients. This minimally invasive approach offers a good safety profile with sustained results up to one year.
Area of Science:
- Pulmonary Medicine
- Interventional Pulmonology
- Respiratory Disease Research
Background:
- Advanced emphysema and hyperinflation significantly impair exercise capacity and pulmonary function.
- Minimally invasive bronchoscopic lung volume reduction techniques are being investigated as alternatives to lung volume reduction surgery (LVRS).
- Lung volume reduction coil (LVRC) treatment is one such investigational approach.
Purpose of the Study:
- To evaluate the feasibility, safety, and efficacy of LVRC treatment in a multi-center setting for patients with severe emphysema.
- To assess the clinical improvements and long-term outcomes of LVRC treatment.
Main Methods:
- Multi-center clinical investigation of LVRC treatment.
- Assessment of exercise capacity, pulmonary function, safety, and long-term follow-up data.
Main Results:
- LVRC treatment demonstrated significant clinical improvements in patients with severe emphysema in a multicenter analysis.
- The treatment exhibited a good safety profile.
- Sustained positive results were observed for up to one year post-treatment.
Conclusions:
- LVRC treatment appears promising for severe emphysema, offering significant clinical benefits and a favorable safety profile with sustained effects up to one year.
- Further well-designed, controlled trials, including comparisons with LVRS, are necessary before routine clinical adoption of endobronchial coils and other bronchoscopic lung volume reduction methods.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:26Pneumothorax-I
1.9K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.9K
01:05Breathing
66.1K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.1K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:27Pneumothorax-II
1.3K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.3K